![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 01, 2015 2:23:14 PM
The problem is of course not totally as Rake says, but pretty close...till some credible third party shows interest in this company and its so-called wonder drug PRP, the stock will have no following and even the MMs will tire of shorting...if a bunch of sellers dump 30 million shares in a hurry, of course the stock will plummet...till then, it is a show me thing...
The company may well be legit, but when they need to put out a press release about receiving a previously advertised measly 700k from a guy like Sason, that does not bode well about their drug...if they indeed are this close to initiating human trials, then some third party needs to endorse this drug and all that it can do...so far, this has not happened...for a company doing research in two labs in Europe, and using two major facilities in the U.S. to substantiate their research, 2 million $ to cover it all does not speak volumes about the efficacy and potential of this drug...they desperately need to get a big or medium big Pharma to at least say that there is 1 in 1000 chance that this drug might work...right now, its the blind leading the blind, and that means we all go into the ditch...
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM